Search Results - "Elkhuizen, P."

Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period by Bosma, S. C. J., van der Leij, F., van Werkhoven, E., Bartelink, H., Wesseling, J., Linn, S., Rutgers, E. J., van de Vijver, M. J., Elkhuizen, P. H. M.

“…The purpose of this study was to study the impact of changes in clinical practice on outcome in patients treated with breast-conserving therapy (BCT) over a…”
Get full text

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure by van der Noordaa, M. E. M., van Duijnhoven, F. H., Straver, M. E., Groen, E. J., Stokkel, M., Loo, C. E., Elkhuizen, P. H. M., Russell, N. S., Vrancken Peeters, M. T. F. D.

“…Background Axillary lymph node dissection (ALND) is frequently performed for node-positive (cN+) breast cancer patients. Combining positron emission…”
Get full text

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib by de Haan, R, van Werkhoven, E, van den Heuvel, M M, Peulen, H M U, Sonke, G S, Elkhuizen, P, van den Brekel, M W M, Tesselaar, M E T, Vens, C, Schellens, J H M, van Triest, B, Verheij, M

“…Poly (ADP-ribose) Polymerase (PARP) inhibitors are promising novel radiosensitisers. Pre-clinical models have demonstrated potent and tumour-specific…”
Get full text

Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer by van der Noordaa, M E M, van Duijnhoven, F H, Cuijpers, F N E, van Werkhoven, E, Wiersma, T G, Elkhuizen, P H M, Winter-Warnars, G, Dezentje, V, Sonke, G S, Groen, E J, Stokkel, M, Vrancken Peeters, M T F D

“…The nodal positivity rate after neoadjuvant chemotherapy (ypN+) in patients with clinically node-negative (cN0) breast cancer is low, especially in those with…”
Get full text

Who does not need radiation? by Elkhuizen, P

Get full text

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis by Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van ’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

“…The 70-gene signature (MammaPrint™) has been developed to predict the risk of distant metastases in breast cancer and select those patients who may benefit…”
Get full text

Evaluation of delineating the target volume by radiation therapists in breast cancer patients by van Pelt, V.W.J., Gerrets, S., Simões, R., Elkhuizen, P.H.M., Janssen, T.M.

“…Breast radiotherapy accounts for a significant workload in radiotherapy departments. In 2015 it became clinical practice at the Netherlands Cancer Institute…”
Get full text

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer by Voogd, A.C., van Oost, F.J., Rutgers, E.J.T., Elkhuizen, P.H.M., van Geel, A.N., Scheijmans, L.J.E.E., van der Sangen, M.J.C., Botke, G., Hoekstra, C.J., Jobsen, J.J., van de Velde, C.J.H., von Meyenfeldt, M.F., Tabak, J.M., Peterse, J.L., van de Vijver, M.J., Coebergh, J.W.W., van Tienhoven, G.

“…We have studied the long-term prognosis of 266 patients considered to have isolated local recurrence in the breast following conservative surgery and…”
Get full text

Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis by Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Get full text

Interobserver variability in the radiological assessment of response to chemotherapy in glioma by VOS, M. J, UITDEHAAG, B. M. J, BARKHOF, F, HEIMANS, J. J, BAAYEN, H. C, BOOGERD, W, CASTELIJNS, J. A, ELKHUIZEN, P. H. M, POSTMA, T. J

“…To assess the interobserver variability in the radiologic assessment of response to chemotherapy in patients with recurrent glioma. Five clinicians with…”
Get full text

OC-0551 PREOPERATIVE ACCELERATED PARTIAL BREAST IRRADIATION: VMAT VERSUS IMRT COMPARISON USING PARETO FRONTS by Wolf, A, Janssen, T, Duijn, A, Elkhuizen, P, Vreeswijk, S, Damen, E, van Vliet-Vroegindewij, C

Get full text

458 poster ASSESSMENT OF INTRA-FRACTION MOTION DURING PARTIAL BREAST IRRADIATION by Bouzeya, N, Vreeswijk, S, Elkhuizen, P, Sonke, J.J, van-Vroegindeweij, C. Vliet, Remeijer, P

Get full text

PD-0492 SEROMA VOLUME CHANGE AS AN INDICATOR FOR THE NEED OF REPLANNING DURING ADAPTIVE RT OF BREAST CANCER by Franssen, G, Alderliesten, T, van Kesteren, Z, Elkhuizen, P, Conijn, S, Duijn, A, Janssen, T, Remeijer, P, van Vliet-Vroegindeweij, C

Get full text

1277 poster REDUCING INTER-OBSERVER VARIATION OF BOOST-CTV DELINEATION IN BREAST CONSERVING THERAPY USING A PRE-OPERATIVE CT by Boersma, L, Janssen, T, Elkhuizen, P, Poortmans, P, Van der Sangen, M, Scholten, A, Hurkmans, C, van Vliet-Vroegindeweij, C

Get full text

Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival by Elkhuizen, P H, van de Vijver, M J, Hermans, J, Zonderland, H M, van de Velde, C J, Leer, J W

“…To study risk factors for local recurrence (LR) after breast-conserving therapy (BCT) for invasive breast cancer and, for patients with an LR, the mode of…”
Get more information

CLINICAL APPLICABILITY OF CONE-BEAM CT IN MONITORING SEROMA REDUCTION IN BREAST-CONSERVING THERAPY by Yang, T.I.J, Minkema, D, Elkhuizen, P, Heemsbergen, W, van Mourik, A, van Vliet-Vroegindewij, C

Get full text

SEROMA AFTER BREAST CONSERVING SURGERY: A COMPARISON OF THREE RADIOTHERAPY PLANNING TECHNIQUES by Den Hollander, S, Alderliesten, T, Yang, J, Elkhuizen, P, van Mourik, A, Hurkmans, C, van Vliet-Vroegindewij, C

Get full text

High Local Recurrence Risk After Breast-Conserving Therapy in Node-Negative Premenopausal Breast Cancer Patients Is Greatly Reduced by One Course of Perioperative Chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study by ELKHUIZEN, P. H. M, VAN SLOOTEN, H.-J, CLAHSEN, P. C, HERMANS, J, VAN DE VELDE, C. J. H, VAN DEN BROEK, L. C. J. M, VAN DE VIJVER, M. J

“…Patients with invasive breast cancer may develop a local recurrence (LR) after breast-conserving therapy (BCT). Younger age has been found to be an independent…”
Get full text

Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer by Voogd, A.C., Peterse, J.L., Crommelin, M.A., Rutgers, E.J.Th, Botke, G., Elkhuizen, P.H.M., van Geel, A.N., Hoekstra, C.J.M., van Pel, R., van de Vijver, M.J., Coebergh, J.W.W.

“…The purpose of this study was to determine which histological factors are associated with an increased risk for local recurrence in the breast after…”
Get full text

Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression by Elkhuizen, P H, Voogd, A C, van den Broek, L C, Tan, I T, van Houwelingen, H C, Leer, J W, van de Vijver, M J

“…Many studies have focused on histological risk factors for local recurrence (LR) after breast-conserving therapy (BCT). In addition to histological factors, we…”
Get more information